Literature DB >> 34483767

Moving on With Monoamine Oxidase Inhibitors.

J Alexander Bodkin1, Boadie W Dunlop1.   

Abstract

Entities:  

Keywords:  Administration & management; MAO inhibitors

Year:  2021        PMID： 34483767      PMCID： PMC8412161          DOI： 10.1176/appi.focus.20200046

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN： 1541-4094


× No keyword cloud information.
  11 in total

Review 1.  The role of dopamine in the pathophysiology of depression.

Authors:  Boadie W Dunlop; Charles B Nemeroff
Journal:  Arch Gen Psychiatry       Date:  2007-03

Review 2.  A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.

Authors:  P Ken Gillman
Journal:  Hum Psychopharmacol       Date:  2006-03       Impact factor: 1.672

3.  Management of monoamine oxidase inhibitor-associated insomnia with trazodone.

Authors:  A A Nierenberg; P E Keck
Journal:  J Clin Psychopharmacol       Date:  1989-02       Impact factor: 3.153

4.  Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.

Authors:  F M Quitkin; P J McGrath; J W Stewart; W Harrison; E Tricamo; S G Wager; K Ocepek-Welikson; E Nunes; J G Rabkin; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1990-10

Review 5.  The making of a user friendly MAOI diet.

Authors:  D M Gardner; K I Shulman; S E Walker; S A Tailor
Journal:  J Clin Psychiatry       Date:  1996-03       Impact factor: 4.384

6.  A survey of prescribing practices for monoamine oxidase inhibitors.

Authors:  R Balon; R Mufti; C L Arfken
Journal:  Psychiatr Serv       Date:  1999-07       Impact factor: 3.084

7.  Selegiline transdermal system: in the treatment of major depressive disorder.

Authors:  James E Frampton; Greg L Plosker
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.

Authors:  F M Quitkin; J W Stewart; P J McGrath; M R Liebowitz; W M Harrison; E Tricamo; D F Klein; J G Rabkin; J S Markowitz; S G Wager
Journal:  Am J Psychiatry       Date:  1988-03       Impact factor: 18.112

9.  The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial.

Authors:  J Razani; K L White; J White; G Simpson; R B Sloane; R Rebal; R Palmer
Journal:  Arch Gen Psychiatry       Date:  1983-06

Review 10.  Atypical depression: useful concept, but it's time to revise the DSM-IV criteria.

Authors:  Michael E Thase
Journal:  Neuropsychopharmacology       Date:  2009-09-09       Impact factor: 7.853
View more
  1 in total

1.  Analysis of the Underlying Mechanism of the Jiu Wei Zhen Xin Formula for Treating Generalized Anxiety Disorder Based on Network Pharmacology of Traditional Chinese Medicine.

Authors:  Heng Shao; Quan Gan; Zhuangfei Chen; Shasha Zhu; Yanqing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-29       Impact factor: 2.650
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.